Liver transplantation is the only curative option for end-stage liver disease, but its applicability is limited by donor shortages. Hepatocyte transplantation offers a promising alternative, particularly for pediatric acute liver failure, yet its success relies on the availability of viable cells. Cryopreservation enables off-the-shelf use, though long-term storage may impair cell quality. This study investigates whether cryostorage duration, donor characteristics, and organ retrieval parameters affect the viability and functionality of cryopreserved primary human hepatocytes (PHHs). We conducted a retrospective analysis of 144 thawing events across 81 GMP-grade hepatocyte batches, cryopreserved for up to 14 years. Donor age ranged from 3 days to 70 years. Viability and functionality were assessed using MTT assays, albumin and urea secretion, and CYP450 activity. Linear regression was used to analyze correlations (P R2 = 0.035, P = 0.029), yield (R2 = 0.039, P = 0.041), and metabolic activity (R2 = 0.278, P = 0.008), while showing a positive correlation with induced ethoxy resorufin O-demethylation (EROD) function (R2 = 0.432, P = 0.020). Donor body mass index (BMI) showed significant negative associations with viability (R2 = 0.075, P = 0.003), yield (R2 = 0.069, P = 0.011), and metabolic activity (R2 = 0.267, P = 0.019). Cold ischemia time (CIT) showed a weak negative correlation with viability (R2 = 0.151, P < 0.0001), particularly when CIT exceeded ~10 h and viability fell below 60%. Clinical-grade cryopreserved hepatocytes retain viability and function for over a decade. CIT, donor BMI, and age impacted post-thaw quality, while warm ischemia time (WIT), within our current criteria, and storage duration had minimal impact. These findings support refining donor selection to improve cryopreservation outcomes.
Güven et al. (Wed,) studied this question.